Related Experiment Videos
Transfusion therapy in emergency medicine.
M S Kruskall1, P D Mintz, J J Bergin
1Department of Pathology, Beth Israel Hospital, Boston, Massachusetts 02215.
Annals of Emergency Medicine
|April 1, 1988
Summary
Volume replacement in hemorrhaging patients is crucial. Use crystalloids, colloids, and red blood cells judiciously, avoiding plasma as a volume expander and unnecessary platelet transfusions.
Area of Science:
- Transfusion Medicine
- Critical Care Medicine
- Hematology
Background:
- Volume replacement is essential for hemorrhaging patients.
- Red blood cells are vital for treating tissue hypoxia from anemia.
- The use of whole blood versus packed red blood cells remains debated.
Purpose of the Study:
- To outline appropriate strategies for fluid and blood product resuscitation.
- To clarify the indications for plasma and platelet transfusions.
- To discuss the risks and benefits of massive transfusion protocols.
Main Methods:
- Review of current transfusion guidelines and clinical practices.
- Analysis of the efficacy and risks associated with different resuscitation fluids.
- Evaluation of laboratory monitoring for transfusion management.
Main Results:
- Crystalloids and colloids are effective for initial volume replacement.
- Red blood cells are indicated for anemia-related tissue hypoxia.
- Plasma and platelet transfusions should be guided by specific clinical indications and laboratory findings, not routine prophylaxis.
- Many feared complications of massive transfusion are rare; risks of hemolysis and disease transmission are significant.
- Blood conservation strategies, including autologous blood use, are advantageous.
Conclusions:
- Judicious use of blood components is critical, balancing resuscitation needs with transfusion risks.
- Transfusion decisions should be evidence-based, guided by patient-specific factors and laboratory data.
- Emphasis on blood conservation and appropriate component therapy improves patient outcomes.